Clinical Trials on Liposarcoma, Dedifferentiated in United Kingdom
Total 580 results
-
Memorial Sloan Kettering Cancer CenterIncyte CorporationActive, not recruitingWell-differentiated/Dedifferentiated LiposarcomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingSarcoma | Soft Tissue Sarcoma | Sarcoma,Soft Tissue | Dedifferentiated Liposarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Unresectable Dedifferentiated LiposarcomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingUndifferentiated Pleomorphic Sarcoma | Recurrent Undifferentiated Pleomorphic Sarcoma | Dedifferentiated Liposarcoma | Resectable Dedifferentiated Liposarcoma | Resectable Undifferentiated Pleomorphic Sarcoma | Recurrent Dedifferentiated LiposarcomaUnited States
-
Sarcoma Alliance for Research through CollaborationEli Lilly and CompanyRecruitingAdvanced Dedifferentiated LiposarcomaUnited States
-
European Organisation for Research and Treatment...SanofiCompletedDedifferentiated LiposarcomaUnited Kingdom, Belgium, France, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Osteosarcoma | Refractory Osteosarcoma | Metastatic Osteosarcoma | Metastatic Angiosarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Recurrent Angiosarcoma | Refractory Dedifferentiated LiposarcomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Advanced Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Locally Advanced Dedifferentiated Liposarcoma | Unresectable Dedifferentiated...United States
-
Boehringer IngelheimRecruitingLiposarcoma, DedifferentiatedUnited States, Australia, Canada, United Kingdom, Japan, Brazil, Argentina
-
Memorial Sloan Kettering Cancer CenterENABLE MEDICINEActive, not recruitingSarcoma | Leiomyosarcoma | High Grade Sarcoma | Undifferentiated Pleomorphic Sarcoma | Advanced Sarcoma | Myxofibrosarcoma | Dedifferentiated LiposarcomaUnited States
-
Karyopharm Therapeutics IncCompletedDedifferentiated LiposarcomaUnited States, United Kingdom, Israel, France, Canada, Spain, Belgium, Sweden, Germany, Italy
-
Memorial Sloan Kettering Cancer CenterEli Lilly and CompanyActive, not recruitingSarcoma | Dedifferentiated LiposarcomaUnited States
-
Infinity Pharmaceuticals, Inc.WithdrawnDedifferentiated LiposarcomaUnited States
-
Rain Oncology IncTerminatedDedifferentiated LiposarcomaUnited States, Spain, France, Korea, Republic of, Taiwan, Canada, Hong Kong, Austria, Germany, Belgium, Georgia, Ireland, Italy, Poland, United Kingdom
-
Boehringer IngelheimActive, not recruitingLiposarcoma, DedifferentiatedUnited States, Spain, Canada, Taiwan, Belgium, Australia, China, Italy, Germany, Japan, Hong Kong, Finland, United Kingdom, Denmark, France, Sweden, Netherlands, Portugal, Czechia, Greece, Norway
-
Shanghai Pharma Biotherapeutics USA Inc.RecruitingLiposarcoma, DedifferentiatedUnited States
-
Fred Hutchinson Cancer CenterIncyte CorporationTerminatedRefractory Soft Tissue Sarcoma | Metastatic Leiomyosarcoma | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Advanced Synovial Sarcoma | Metastatic Chondrosarcoma | Advanced Leiomyosarcoma | Metastatic Myxoid... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Pleomorphic Liposarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Metastatic Unresectable Sarcoma | Unresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue Sarcoma | Metastatic... and other conditionsUnited States
-
The Netherlands Cancer InstituteUnknownMyxoid Liposarcoma of Soft TissueNetherlands, United Kingdom, Norway, United States, Denmark
-
National Cancer Institute (NCI)SuspendedLocally Advanced Leiomyosarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Locally Advanced Liposarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Locally Advanced Extraskeletal Myxoid Chondrosarcoma | Locally Advanced Unresectable Soft Tissue SarcomaUnited States, Canada
-
Sumitomo Pharma America, Inc.TerminatedSarcoma | Ewing Sarcoma | Advanced Solid Tumors | Synovial Sarcoma | Dedifferentiated LiposarcomaUnited States
-
GlaxoSmithKlineActive, not recruitingNeoplasmsUnited States, Netherlands, Canada, United Kingdom
-
National Cancer Institute (NCI)TerminatedThyroid Neoplasms | Differentiated Thyroid Cancer | Poorly Differentiated and Undifferentiated Thyroid CancerUnited States
-
OHSU Knight Cancer InstituteNovartis Pharmaceuticals; Oregon Health and Science UniversityCompletedStage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Locally Advanced Leiomyosarcoma | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Unresectable... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight TherapeuticsActive, not recruitingLeiomyosarcoma | Malignant Peripheral Nerve Sheath Tumor | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Undifferentiated High Grade Pleomorphic Sarcoma of Bone | Myxofibrosarcoma | Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage III Soft Tissue Sarcoma of the... and other conditionsUnited States
-
AdaptimmuneRecruitingMyxoid Liposarcoma | Synovial SarcomaUnited States, United Kingdom, Canada, France, Spain
-
GlaxoSmithKlineCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedLiposarcoma,MyxoidFrance, United States, Germany
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruitingSarcoma | Leiomyosarcoma | Liposarcoma | Undifferentiated Pleomorphic SarcomaUnited States
-
Michael WagnerEdgewood Oncology Inc.Not yet recruitingLiposarcoma | MDM2 Gene Amplification | Metastatic Liposarcoma | Unresectable Liposarcoma | Recurrent LiposarcomaUnited States
-
Systems Medicine LLCUnknown
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Horizon Pharma USA, Inc.TerminatedMyxoid Liposarcoma | Synovial Sarcoma | Round Cell LiposarcomaUnited States
-
University of LeedsTerminatedSarcoma | Leiomyosarcoma | LiposarcomaUnited Kingdom
-
M.D. Anderson Cancer CenterSuspendedMyxoid/Round Cell Liposarcoma | Synovial SarcomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); EMD SeronoTerminatedMetastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Metastatic Liposarcoma | Unresectable LiposarcomaUnited States
-
Vector OncologyNovartisCompletedLiposarcoma | Surgically Unresectable Liposarcoma | Metastatic LiposarcomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Daiichi Sankyo, Inc.Completed
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Germany, Netherlands, Canada, Australia, Sweden
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Janssen PharmaceuticalsWithdrawnMyxoid Liposarcoma | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Round Cell Liposarcoma | Unresectable Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Matthew InghamMirati Therapeutics Inc.Active, not recruitingLiposarcoma | Metastatic LiposarcomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedSolid Tumors | Virally Mediated Cancers and LiposarcomaUnited States
-
Immune DesignGenentech, Inc.TerminatedSarcoma | Myxoid/Round Cell Liposarcoma | Liposarcoma | Synovial Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced SarcomaUnited States
-
M.D. Anderson Cancer CenterCompletedRecurrent Synovial Sarcoma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells Present | Recurrent Myxoid LiposarcomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnMyxoid/Round Cell Liposarcoma | Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Synovial SarcomaUnited States
-
University of PennsylvaniaParker Institute for Cancer Immunotherapy; Tmunity TherapeuticsTerminatedMelanoma | Multiple Myeloma | Myxoid/Round Cell Liposarcoma | Synovial SarcomaUnited States
-
Royal Marsden NHS Foundation TrustEuropean CommissionRecruitingDifferentiated Thyroid CancerUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI); GlaxoSmithKlineCompletedRecurrent Osteosarcoma | Metastatic Osteosarcoma | Recurrent Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Liposarcoma | Metastatic Liposarcoma | Recurrent LiposarcomaUnited States
-
Fox Chase Cancer CenterRecruitingSoft Tissue Sarcoma | Retroperitoneal LiposarcomaUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCActive, not recruiting
-
Hospital for Special Surgery, New YorkRecruitingUndifferentiated Connective Tissue DiseaseUnited States
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia